These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 8007761)

  • 41. Synthesis and in vitro binding properties of halogenated analogues of GBR as new dopamine uptake carrier ligands.
    Foulon C; Garreau L; Chalon S; Desplanches G; Frangin Y; Besnard JC; Baulieu JL; Guilloteau D
    Int J Rad Appl Instrum B; 1992 Jul; 19(5):597-600. PubMed ID: 1399689
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Studies of the biogenic amine transporters. III. Demonstration of two binding sites for [3H]GBR12935 and [3H]BTCP in rat caudate membranes.
    Akunne HC; Dersch CM; Cadet JL; Baumann MH; Char GU; Partilla JS; de Costa BR; Rice KC; Carroll FI; Rothman RB
    J Pharmacol Exp Ther; 1994 Mar; 268(3):1462-75. PubMed ID: 7908058
    [TBL] [Abstract][Full Text] [Related]  

  • 43. A pharmacological comparison of [3H]GBR12935 binding to rodent striatal and kidney homogenates: binding to dopamine transporters?
    Sharif NA; Nunes JL; Kalfayan V; McClelland DL; Rosenkranz RP; Eglen RM; Whiting RL
    Neurochem Int; 1992 Jul; 21(1):69-73. PubMed ID: 1303143
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Binding characteristics of the dopamine uptake inhibitor [3H]nomifensine to striatal membranes.
    Dubocovich ML; Zahniser NR
    Biochem Pharmacol; 1985 Apr; 34(8):1137-44. PubMed ID: 3158318
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Cocaine and GBR 12783 recognize nonidentical, overlapping binding domains on the dopamine neuronal carrier.
    Saadouni S; Refahi-Lyamani F; Costentin J; Bonnet JJ
    Eur J Pharmacol; 1994 Jul; 268(2):187-97. PubMed ID: 7957640
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [3H]GBR 12935 binding to dopamine uptake sites: subcellular localization and reduction in Parkinson's disease and progressive supranuclear palsy.
    Maloteaux JM; Vanisberg MA; Laterre C; Javoy-Agid F; Agid Y; Laduron PM
    Eur J Pharmacol; 1988 Nov; 156(3):331-40. PubMed ID: 3215281
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Complex ionic control of [3H]GBR 12783 binding to the dopamine neuronal carrier.
    Héron C; Billaud G; Costentin J; Bonnet JJ
    Eur J Pharmacol; 1996 Apr; 301(1-3):195-202. PubMed ID: 8773464
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Characteristics of [3H]GBR 12935 binding in the human and rat frontal cortex.
    Hitri A; Venable D; Nguyen HQ; Casanova MF; Kleinman JE; Wyatt RJ
    J Neurochem; 1991 May; 56(5):1663-72. PubMed ID: 1901595
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Modulatory effect of agents active in the presynaptic dopaminergic system on the striatal dopamine transporter.
    Gordon I; Weizman R; Rehavi M
    Eur J Pharmacol; 1996 Feb; 298(1):27-30. PubMed ID: 8867915
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Cocaine displaces [3H]WIN 35,428 binding to dopamine uptake sites in vivo more rapidly than mazindol or GBR 12909.
    Pögün S; Scheffel U; Kuhar MJ
    Eur J Pharmacol; 1991 Jun; 198(2-3):203-5. PubMed ID: 1864307
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Relationship between [3H]mazindol binding to dopamine uptake sites and [3H]dopamine uptake in rat striatum during aging.
    Shimizu I; Prasad C
    J Neurochem; 1991 Feb; 56(2):575-9. PubMed ID: 1988557
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Correlation between (3H)dopamine specific uptake and (3H)GBR 12783 specific binding during the maturation of rat striatum.
    Bonnet JJ; Costentin J
    Life Sci; 1989; 44(23):1759-65. PubMed ID: 2733550
    [TBL] [Abstract][Full Text] [Related]  

  • 53. In vivo occupancy of the striatal dopamine uptake complex by various inhibitors does not predict their effects on locomotion.
    Vaugeois JM; Bonnet JJ; Duterte-Boucher D; Costentin J
    Eur J Pharmacol; 1993 Jan; 230(2):195-201. PubMed ID: 8422901
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Neuropeptide-dopamine interactions. V. Cyclo(His-Pro) regulation of striatal dopamine transporter complex.
    Ikegami H; Prasad C
    Peptides; 1990; 11(1):145-8. PubMed ID: 2342989
    [TBL] [Abstract][Full Text] [Related]  

  • 55. In vivo binding of [18F]GBR 13119 to the brain dopamine uptake system.
    Kilbourn MR
    Life Sci; 1988; 42(14):1347-53. PubMed ID: 3352457
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [3H]GBR 12935 binding in platelets: a possible association with cytochrome P-450IID6?
    Norlén M; Allard P
    Eur J Pharmacol; 1997 Aug; 332(2):227-30. PubMed ID: 9286626
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Specific binding of 1-[2-(diphenylmethoxy)ethyl]-4-(3-phenyl propyl) piperazine (GBR-12935), an inhibitor of the dopamine transporter, to human CYP2D6.
    Hiroi T; Imaoka S; Chow T; Yabusaki Y; Funae Y
    Biochem Pharmacol; 1997 Jun; 53(12):1937-9. PubMed ID: 9256169
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Identification of dopamine transporter in bovine pineal gland using [3H]GBR 12935.
    Govitrapong P; Vilaipun P; Ebadi M
    J Pineal Res; 2003 Aug; 35(1):16-23. PubMed ID: 12823609
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Time course of postmortem modifications in synaptosomal [3H]dopamine uptake and [3H]GBR 12783 binding to the dopamine uptake complex in the rat striatum.
    Thibaut F; Bonnet JJ; Costentin J
    Neurosci Lett; 1989 Jan; 96(3):335-9. PubMed ID: 2717059
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Evidence for the sequential formation of two complexes between an uptake inhibitor, GBR 12783 [1-[2-(diphenylmethoxy)ethyl]-4-(3-phenyl-2-propenyl)piperazine], and the neuronal transporter of dopamine.
    Do-Régo JC; Hue H; Costentin J; Bonnet JJ
    J Neurochem; 1999 Jan; 72(1):396-404. PubMed ID: 9886093
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.